Requirements

All of it, confirmed on 18/09/2026 and shaped by OQ-05 and OQ-18. A pharma user first meets an anonymous card: profession, country and topic, with no name, no employer and no question text. The profile proper opens only after the expert accepts a contact request, and then carries name, affiliation, specialty, the topic signal summary, the fit score, papers and trials. Optional fields appear when available: country, congress talks, guideline and society roles, grants, KOL type and last-updated dates. Every profile carries a completion score the customer can see, which sorts and scores nothing (OQ-18, NP-06). The expert may sign in with ORCID to fill the optional fields, see the topics flagged for them, and withdraw entirely (NP-06, FD-03). The 12 researchers of the August 2026 note appear nowhere (OQ-33).

Still held. Nothing. Two rules travel with the profile: a withdrawal deletes the expert's stored signals, recalculates the affected totals and re-applies the minimums (OQ-34, FD-03), and tumour-board membership appears only inside a revealed profile, never on a card, an export or an API answer that precedes an acceptance (NP-02).

Released by OQ-05, OQ-18, OQ-33, NP-02, NP-06, FD-03.

All of it. OQ-18 names the core set that is required: name, affiliation, specialty, topic signal summary, fit score, papers and trials. Everything else is optional and shown when available. The completion score is visible to the customer and to the expert, and no scoring or sorting rule may read it (NP-06): it exists to motivate an expert to fill their profile, and a completion score that moved rank would be a ranking of who filled in a form.

Still held. Nothing. Two exclusions are permanent rather than pending: no conflict-of-interest field, flag or note anywhere (NP-09), and no payment, claims or prescribing data (OQ-28). A field fed by a paid source would need its own decision, a written licence and a visible source label (NP-05); none is licensed at launch.

Released by OQ-18, NP-05, NP-06, NP-09.